Estrogen levels tied to risk for sudden cardiac death in study
(HealthDay)—Higher levels of the hormone estrogen are associated with an increased risk of sudden cardiac death in men and women, a new study suggests.
May 11, 2013
0
0
(HealthDay)—Higher levels of the hormone estrogen are associated with an increased risk of sudden cardiac death in men and women, a new study suggests.
May 11, 2013
0
0
(HealthDay)—Sprawled out on the couch, reading the news on your iPad, you'd never think you could be putting yourself at risk. But you might be, if you happen to have an implanted heart device.
May 9, 2013
0
0
A University of Michigan study from the "Online First" edition of Anesthesiology found cardiac arrest was associated with improved survival when it occurred in the operating room (O.R.) or post-anesthesia care unit (PACU) ...
May 1, 2013
0
0
The antibiotic clarithromycin – widely used for treating lower respiratory tract infections like pneumonia and acute exacerbations (sudden worsening) of chronic obstructive pulmonary disease (COPD) – may be associated ...
Mar 21, 2013
0
0
Energy drinks may increase blood pressure and disturb your heart's natural rhythm, according to research presented at the American Heart Association's Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism ...
Mar 21, 2013
0
0
For the first time, a UCLA team has used a technique normally employed in treating brain aneurysms to treat severe, life-threatening irregular heart rhythms in two patients.
Mar 14, 2013
0
0
A team led by Vanderbilt University investigators has discovered two new genes – both coding for the signaling protein calmodulin – associated with severe early-onset disorders of heart rhythm. The findings, reported ...
Feb 6, 2013
0
0
(HealthDay)—Most heart patients with implantable cardioverter-defibrillators (ICDs) would prefer to switch off the device if they had an advanced illness, new research suggests.
Jan 30, 2013
0
0
A computer model of the heart wall predicted risk of irregular heart rhythms and sudden cardiac death in patients, paving the way for the use of more complex cardiac models to calculate the consequences of genetic, lifestyle ...
Dec 13, 2012
0
0
(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...
Dec 6, 2012
0
0